TCG Crossover Management »

Xencor shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Xencor (XNCR) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Xencor

Tip: Access up to 7 years of quarterly data

All positions including Xencor held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xencor by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $29M 2.5M 11.73
2025-06-30 $19M 2.5M 7.86
2025-03-31 $26M 2.5M 10.64
2024-12-31 $56M 2.5M 22.98
2024-09-30 $49M 2.4M 20.11

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Amylyx Pharmaceuticals Comm (AMLX)
Centessa Pharmaceuticals Adrs (CNTA)
Tango Therapeutics Comm (TNGX)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Tourmaline Bio Comm (TRML)
Dyne Therapeutics Comm (DYN)
Agios Pharmaceuticals Comm (AGIO)
Eyepoint Pharmaceuticals Comm (EYPT)
Fulcrum Therapeutics Comm (FULC)
Savara Comm (SVRA)
Rapt Therapeutics Comm (RAPT)

View all positions for TCG Crossover Management

Top funds holding Xencor

BlackRock
PRIMECAP Management Company
Vanguard Group
Rtw Investments
EcoR1 Capital
State Street Corporation
BVF
TCG Crossover Management
Geode Capital Management
Dimensional Fund Advisors
Legal & General Group
Braidwell
UBS Group
Baker Bros. Advisors
Nantahala Capital Management

View all funds holding Xencor